Transplantation in Acute‐on‐Chronic Liver Failure: Feasibility and Futility
Alexander Queck, Nina Weiler, Jonel Trebicka – 19 May 2022
Posttransplant complications in the setting of acute‐on‐chronic liver failure and considerations regarding immunosuppression
M. Valerie Lin, Fredric D. Gordon – 19 May 2022
Con: Patients With Acute‐on‐Chronic Liver Failure Should Not Receive Priority on the Waiting List
Nadim Mahmud, K. Rajender Reddy – 19 May 2022
Transplantation in Acute‐on‐Chronic Liver Failure: Feasibility and Futility
Alexander Queck, Nina Weiler, Jonel Trebicka – 19 May 2022
Palliative Care in the Patient With Acute‐on‐Chronic Liver Failure
Kinjal Patel, Puneeta Tandon, Ruben Hernaez – 19 May 2022
PRO: Patients With Acute‐on‐Chronic Liver Failure Should Receive Priority on the Liver Transplant Waiting List
Rachel H. Westbrook, Elaine L. Burrell, Rajiv Jalan – 19 May 2022
Palliative Care in the Patient With Acute‐on‐Chronic Liver Failure
Kinjal Patel, Puneeta Tandon, Ruben Hernaez – 19 May 2022
Mas‐related G protein‐coupled receptor type D antagonism improves portal hypertension in cirrhotic rats
Lakmie S. Gunarathne, Indu G. Rajapaksha, Stephen Casey, Tawar Qaradakhi, Anthony Zulli, Harinda Rajapaksha, Jonel Trebicka, Peter W. Angus, Chandana B. Herath – 19 May 2022 – Splanchnic vasodilatation contributes to the development and aggravation of portal hypertension (PHT). We previously demonstrated that in cirrhosis, angiotensin‐ mediates splanchnic vasodilatation through the Mas receptor (MasR).
Reply
Christian A. Hudert, Jake P. Mann – 19 May 2022
Posttransplant complications in the setting of acute‐on‐chronic liver failure and considerations regarding immunosuppression
M. Valerie Lin, Fredric D. Gordon – 19 May 2022